세계의 식도 연하곤란 시장 보고서(2025년)
Esophageal Dysphagia Global Market Report 2025
상품코드 : 1824662
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

식도 연하곤란 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.7%를 나타내 28억 4,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 비만의 유행, 낮은 침습 수술, 맞춤형 의료, 식도 연하곤란 관리의 세계적인 확대로 인한 것입니다. 예측 기간의 주요 동향은 환자 중심의 치료, 원격 의료 및 원격 모니터링, 영양 지원, 연구 협력 등이 있습니다.

향후 5년간의 성장률 6.7%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 상승은 스웨덴과 한국에서 조달하는 신경계 시스템과 확장 풍선의 비용을 밀어 올리고, 연하곤란 관리의 과제를 악화시키고, 소화기계 처치의 비용을 상승시킴으로써, 미국의 병원에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

흡연자 증가는 향후 식도 연하곤란 시장 성장을 이끌 것으로 예측됩니다. 흡연자는 담배, 시가, 파이프 등의 담배 제품을 습관적으로 피우는 사람입니다. 흡연은 식도에 자극과 손상을 주어 식도 연하곤란를 악화시켜 다양한 건강 합병증을 일으킬 수 있습니다. 식도 연하곤란의 치료는 영양과 수분 보급을 강화하고, 삼키는 위험을 낮추고, 삶의 질을 향상시켜 환자를 지원합니다. 예를 들어 2022년 7월 미국을 기반으로 하는 시가 업계의 전국적인 업계 단체인 시가 어소시에이션 오브 아메리카(Cigar Association of America)는 2023년 미국이 수입한 프리미엄 시가는 약 4억 6,760만개로 2022년 대비 0.7% 증가한 수치라고 보고했습니다. 이와 같이 흡연자 수 증가가 식도 연하곤란 시장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 태와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Esophageal dysphagia is a medical condition marked by difficulty in swallowing solid or liquid foods due to structural or functional abnormalities in the esophagus, lower esophageal sphincter (LES), or cardia. It can result from various underlying conditions that disrupt the normal functioning of the esophagus or impede the smooth passage of food and liquids.

The primary treatments for esophageal dysphagia encompass esophageal dilation, surgical intervention, stent placement, laparoscopic Heller myotomy, medications, and lifestyle adjustments. Esophageal dilation is a medical procedure employed to widen a narrowed or constricted segment of the esophagus, commonly used to address esophageal dysphagia stemming from esophageal strictures. Diagnosis of esophageal dysphagia can be achieved through dynamic swallowing studies, X-rays, endoscopy, manometry, imaging scans, including magnetic resonance imaging (MRI) and computed tomography (CT) scans. Various healthcare facilities, such as hospitals, clinics, ambulatory surgical centers, diagnostic centers, and research centers, serve as end-users for managing this condition.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The esophageal dysphagia market research report is one of a series of new reports from The Business Research Company that provides esophageal dysphagia market statistics, including esophageal dysphagia industry global market size, regional shares, competitors with an esophageal dysphagia market share, detailed esophageal dysphagia market segments, market trends and opportunities and any further data you may need to thrive in the esophageal dysphagia industry. This esophageal dysphagia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The esophageal dysphagia market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to aging population, gastroesophageal reflux disease (gerd), advances in endoscopy, esophageal motility testing.

The esophageal dysphagia market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to obesity epidemic, minimally invasive procedures, personalized medicine, global expansion of esophageal dysphagia care. Major trends in the forecast period include patient-centered care, telehealth and remote monitoring, nutritional support, research collaboration.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of manometry systems and dilation balloons sourced from Sweden and South Korea, exacerbating swallowing disorder management challenges and elevating GI procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of smokers is expected to drive the growth of the esophageal dysphagia market going forward. Smokers are individuals who habitually smoke tobacco products, including cigarettes, cigars, or pipes. Smoking can worsen esophageal dysphagia by causing irritation and damage to the esophagus, leading to various health complications. Treatment for esophageal dysphagia supports patients by enhancing nutrition and hydration, lowering the risk of aspiration, and improving quality of life. For example, in July 2022, the Cigar Association of America, a U.S.-based national trade association for the cigar industry, reported that the United States imported approximately 467.6 million premium cigars in 2023, reflecting a 0.7% increase over 2022. Thus, the rising number of smokers is fueling the esophageal dysphagia market.

The increasing prevalence of strokes is also expected to propel the growth of the esophageal dysphagia market. A stroke occurs when a blood vessel in the brain bursts or when blood flow to a part of the brain is obstructed. Stroke can impact brain regions responsible for swallowing, leading to esophageal dysphagia. For instance, in May 2023, Medical Xpress, a U.S.-based web-based medical and health news service provider, reported that worldwide stroke-related deaths are projected to reach nearly 5 million by 2030. Therefore, the growing incidence of strokes is contributing to the expansion of the esophageal dysphagia market.

Leading companies within the esophageal dysphagia market are actively engaged in the development of cutting-edge products that incorporate advanced technologies, such as pharyngeal electrical stimulation (PES) technology. These innovations are aimed at strengthening their relationships with existing customers. Pharyngeal electrical stimulation (PES) technology represents a therapeutic approach specifically designed to address certain swallowing disorders, notably dysphagia resulting from neurological conditions or related factors. As an illustration, in October 2022, Phagenesis Ltd., a UK-based company specializing in dysphagia care, introduced the Phagenyx neurostimulation system, built upon pharyngeal electrical stimulation technology. This system offers a novel rehabilitation treatment for post-stroke dysphagia by enhancing swallowing performance in individuals with neurogenic dysphagia associated with stroke. The method involves direct pharyngeal stimulation using location-specific intraluminal catheters introduced trans nasally. Furthermore, PES technology holds promise in enhancing the quality of life for dysphagia patients, reducing healthcare costs, and broadening its applicability to a wider spectrum of individuals with dysphagia.

In May 2023, Patheous Health Inc., a U.S.-based company specializing in dysphagia care, completed the acquisition of Carolina Speech Pathology LLC for an undisclosed sum. Through this strategic move, Patheous Health Inc. aims to broaden its reach, expand its array of services, and tap into additional talent, thereby gaining a competitive edge in the dysphagia healthcare market. Carolina Speech Pathology LLC is a U.S.-based developer of mobile dysphagia swallow imaging devices, designed to enhance esophageal dysphagia treatment.

Major companies operating in the esophageal dysphagia market are Nestle Health Science S.A., Novartis AG, Fresenius Kabi AG, Abbott Laboratories, Danone S.A., F. Hoffmann-La Roche Ltd., Merck Sharp and Dohme Corp., Pfizer Inc., Ingredion Incorporated, Eikonix Ltd., Olympus Corporation, Eisai Co. Ltd., Aurobindo Pharma Ltd., Dr. Reddys Laboratories, Cook Medical Incorporated, Elekta AB, Johnson and Johnson Ltd., C.R. Bard Inc., Avanos Medical Inc., Cipla Ltd., Kent Precision Foods Group Inc., Nutricia Ltd., CP Kelco Inc., Atos Medical AB, AstraZeneca PLC, NinePoint Medical Inc., Torax Medical Inc., Hormel Health Labs Inc., Dysphagia Management Systems LLC, Biostage Inc.

North America was the largest region in the esophageal dysphagia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in esophageal dysphagia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the esophageal dysphagia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The esophageal dysphagia market consists of revenues earned by entities by providing services such as surgical assistance and physical therapy, clinical evaluation, impedance testing, dietary counseling and surgical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The esophageal dysphagia market also includes the sales of feeding tubes, nasogastric tubes, nutritional solutions, thickeners, beverages, purees, dysphagia diets, esophageal dilation devices, surgical instruments, esophageal pH monitors, corticosteroids, antacids, proton-pump inhibitors (PPIs) and muscle relaxants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Esophageal Dysphagia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on esophageal dysphagia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for esophageal dysphagia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The esophageal dysphagia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Esophageal Dysphagia Market Characteristics

3. Esophageal Dysphagia Market Trends And Strategies

4. Esophageal Dysphagia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Esophageal Dysphagia Growth Analysis And Strategic Analysis Framework

6. Esophageal Dysphagia Market Segmentation

7. Esophageal Dysphagia Market Regional And Country Analysis

8. Asia-Pacific Esophageal Dysphagia Market

9. China Esophageal Dysphagia Market

10. India Esophageal Dysphagia Market

11. Japan Esophageal Dysphagia Market

12. Australia Esophageal Dysphagia Market

13. Indonesia Esophageal Dysphagia Market

14. South Korea Esophageal Dysphagia Market

15. Western Europe Esophageal Dysphagia Market

16. UK Esophageal Dysphagia Market

17. Germany Esophageal Dysphagia Market

18. France Esophageal Dysphagia Market

19. Italy Esophageal Dysphagia Market

20. Spain Esophageal Dysphagia Market

21. Eastern Europe Esophageal Dysphagia Market

22. Russia Esophageal Dysphagia Market

23. North America Esophageal Dysphagia Market

24. USA Esophageal Dysphagia Market

25. Canada Esophageal Dysphagia Market

26. South America Esophageal Dysphagia Market

27. Brazil Esophageal Dysphagia Market

28. Middle East Esophageal Dysphagia Market

29. Africa Esophageal Dysphagia Market

30. Esophageal Dysphagia Market Competitive Landscape And Company Profiles

31. Esophageal Dysphagia Market Other Major And Innovative Companies

32. Global Esophageal Dysphagia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Esophageal Dysphagia Market

34. Recent Developments In The Esophageal Dysphagia Market

35. Esophageal Dysphagia Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기